biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	BFF823F6-9F15-43D8-9D82-09DC9DB78861
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A114-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A114-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A114-01A
biospecimen__bio__biospecimen_barcode_bottom	0108433562
biospecimen__bio__day_of_creation	16
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A114.BACAFF9B-FAC1-49A8-8C56-A0A26794AA1E.pdf
biospecimen__bio__plate_column	3
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	F
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2010
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A114
biospecimen__shared__patient_id	A114
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	4D8CEB97-6323-494B-B23E-D046566001F1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.5
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	2.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.9
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.2
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	21
clinical__chol_lihc_shared__fibrosis_ishak_score	5 - Nodular Formation and Incomplete Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	42
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A114-F38779
clinical__clin_shared__bcr_followup_uuid	DCA31E33-F1CB-4598-A63E-9AE8C8BDCD62
clinical__clin_shared__day_of_form_completion	29
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__platelet_result_count	185
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis C Virus RNA
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2005
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a0e97b20-21a4-45da-b832-ee3d3fc25a79
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A114-01A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	38863191-2a1d-4612-8c81-99f4102555bf
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.82
gdc__analytes__analyte_id	a05aedc4-a0ba-4cac-ab4f-c5229bef40b6
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	02931491-f56b-4233-a079-812e08bc0c59
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	52006106-e643-5fe6-956c-6882c3a90603
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	black or african american
gdc__demographic__year_of_birth	1963
gdc__demographic__year_of_death	2008
gdc__diagnoses__age_at_diagnosis	15410
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-15410.0
gdc__diagnoses__days_to_death	1149.0
gdc__diagnoses__diagnosis_id	7471d1f5-900b-597b-b005-7bc783a12dd1
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	24.725182932941294
gdc__exposures__exposure_id	c18d5a4f-a015-5cb6-a019-beee086486d4
gdc__exposures__height	173.0
gdc__exposures__weight	74.0
gdc__file_id	5fa6477b-1a72-4d2d-b889-e98480a456c1
gdc__file_name	342aff96-4185-4216-ba76-672a53535719.mirbase21.mirnas.quantification.txt
gdc__file_size	50498
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	83ffa2d18c846fa11f9ced3a5fd73679
gdc__portions__is_ffpe	false
gdc__portions__portion_id	ea50cbcf-3b6e-4553-92ba-af9e77155f25
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	2063
gdc__samples__initial_weight	250.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	BACAFF9B-FAC1-49A8-8C56-A0A26794AA1E
gdc__samples__sample_id	8659e0b1-4c44-41e6-b1df-85ae143f40ae
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	2.0
gdc__slides__percent_normal_cells	5.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	70.0
gdc__slides__percent_tumor_nuclei	70.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	7c0dd371-b598-4833-9bc5-f62a0b79c9a6
gdc__submitter_id	mirna_swap_dr11_368_MirnaExpressionf432b8ae-a31a-44dd-a1d0-61fed9ecda70_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	0e12e16a-26cb-5e60-9c10-a1d6cb790835
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:15.078+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a0e97b20-21a4-45da-b832-ee3d3fc25a79-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a0e97b20-21a4-45da-b832-ee3d3fc25a79-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129869
manually_curated__local_md5	5fa7cea00bf2f15b30df52583979bac6
manually_curated__opengdc_download_date	2018-10-16T17:12:07.000649+02:00
manually_curated__opengdc_file_md5	62b6e79b8dc2fc8aedf4086d9c398f7c
manually_curated__opengdc_file_size	50497
manually_curated__opengdc_id	a0e97b20-21a4-45da-b832-ee3d3fc25a79-meq
manually_curated__origin_file_size	129869
manually_curated__origin_last_modified_date	Tue Oct 16 17:13:00 CEST 2018
manually_curated__origin_md5	5fa7cea00bf2f15b30df52583979bac6
manually_curated__tissue_status	tumoral
